BOUNDLESS BIO, INC. Temporary Equity, Shares Issued
BOUNDLESS BIO, INC. (BOLD) had Temporary Equity, Shares Issued of 0 shares as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquitySharesIssued · last filed 2025-03-27
- 2024-12-31: Temporary Equity, Shares Issued 0.00 shares.
- 2024-09-30: Temporary Equity, Shares Issued 0.00 shares.
- 2024-06-30: Temporary Equity, Shares Issued 0.00 shares.
- 2024-03-31: Temporary Equity, Shares Issued 287.45M shares.
| Period end | Temporary Equity, Shares Issued | Temporary Equity, Shares Issued as first filed |
|---|---|---|
| 2024-12-31 | 0.00 shares 10-K · filed 2025-03-27 | |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-12 | |
| 2024-03-31 | 287.45M shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 287.45K shares 10-K · filed 2025-03-27 | 287.45M shares 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |